- Home
- FLUX vs BRNS Comparison
FLUX vs BRNS Comparison
Compare FLUX & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- BRNS
- Stock Information
- Founded
- FLUX N/A
- BRNS 2016
- Country
- FLUX United States
- BRNS United Kingdom
- Employees
- FLUX N/A
- BRNS N/A
- Industry
- FLUX Industrial Machinery/Components
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- FLUX Miscellaneous
- BRNS Health Care
- Exchange
- FLUX Nasdaq
- BRNS Nasdaq
- Market Cap
- FLUX 51.4M
- BRNS 52.0M
- IPO Year
- FLUX N/A
- BRNS 2021
- Fundamental
- Price
- FLUX $2.32
- BRNS $0.99
- Analyst Decision
- FLUX Strong Buy
- BRNS Strong Buy
- Analyst Count
- FLUX 4
- BRNS 2
- Target Price
- FLUX $9.50
- BRNS $4.00
- AVG Volume (30 Days)
- FLUX 67.9K
- BRNS 46.4K
- Earning Date
- FLUX 11-29-2024
- BRNS 11-06-2024
- Dividend Yield
- FLUX N/A
- BRNS N/A
- EPS Growth
- FLUX N/A
- BRNS N/A
- EPS
- FLUX N/A
- BRNS N/A
- Revenue
- FLUX $63,850,000.00
- BRNS $14,969,000.00
- Revenue This Year
- FLUX N/A
- BRNS N/A
- Revenue Next Year
- FLUX $13.51
- BRNS N/A
- P/E Ratio
- FLUX N/A
- BRNS N/A
- Revenue Growth
- FLUX N/A
- BRNS 106.21
- 52 Week Low
- FLUX $2.02
- BRNS $0.81
- 52 Week High
- FLUX $5.86
- BRNS $4.16
- Technical
- Relative Strength Index (RSI)
- FLUX 34.95
- BRNS 37.11
- Support Level
- FLUX $2.02
- BRNS $0.81
- Resistance Level
- FLUX $2.28
- BRNS $1.52
- Average True Range (ATR)
- FLUX 0.22
- BRNS 0.14
- MACD
- FLUX -0.03
- BRNS -0.06
- Stochastic Oscillator
- FLUX 22.99
- BRNS 25.11
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.